Effect of Recombinant FVIII in Healthy Male Subjects Treated With TB-402

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
Single administration of recombinant FVIII/placebo in healthy male subjects who have been treated with a single dose of anti-factor VIII antibody, TB-402
Epistemonikos ID: d330ff65e7eecc0b27be116d80428d8439451ac7
First added on: May 04, 2024